IP Verse

H. Lundbeck A/s competitive analysis

Latest oppositions filed by H. Lundbeck A/s

Explore patent oppositions filed by H. Lundbeck A/s against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
EP1578253
Prevention And Treatment Of Synucleinopathic DiseaseELAN PHARMAMay 18, 2016

Latest patents of H. Lundbeck A/s opposed by its competitors

Explore H. Lundbeck A/s's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4223296
Jan 29, 2025Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations2
EP2608789
Aug 21, 2024Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine1
EP3345604
Jun 7, 2023Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations2
EP3615518
Dec 15, 2021Process For The Manufacture Of Vortioxetine Hbr Alpha-Form1
EP3138564
Jan 31, 2018Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations1
EP2866808
Nov 2, 2016Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations1

Latest PTAB cases involving H. Lundbeck A/s

Discover the latest PTAB cases involving H. Lundbeck A/s, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing H. Lundbeck A/s with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
H LUNDBECK18 - -
ALFRED E TIEFENBACHER765 - -
BIOGARAN13 - - -
ELAN PHARMA - 2 - -